AngioDynamics, Inc. (ANGO)
Largest Insider Buys in Sector
ANGO Stock Price History Chart
ANGO Stock Performance
About AngioDynamics, Inc.
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.
Insider Activity of AngioDynamics, Inc.
Over the last 12 months, insiders at AngioDynamics, Inc. have bought $67,000 and sold $0 worth of AngioDynamics, Inc. stock.
On average, over the past 5 years, insiders at AngioDynamics, Inc. have bought $367,910 and sold $724,304 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Clemmer James C (President and CEO) — $67,000.
The last purchase of 10,000 shares for transaction amount of $67,000 was made by Clemmer James C (President and CEO) on 2024‑04‑08.
List of Insider Buy and Sell Transactions, AngioDynamics, Inc.
| 2024-04-08 | Clemmer James C | President and CEO | 10,000 0.0254% | $6.70 | $67,000 | -6.95% | ||
| 2023-01-31 | Sale | Helsel Dave | SVP Global Operations and R&D | 4,633 0.0117% | $12.95 | $59,997 | -34.41% | |
| 2022-10-12 | Trowbridge Stephen A | EVP and CFO | 1,083 0.0027% | $13.82 | $14,967 | -23.49% | ||
| 2022-10-10 | Clemmer James C | President and CEO | 10,000 0.0264% | $15.00 | $150,000 | -24.76% | ||
| 2022-07-29 | Sale | Helsel Dave | SVP Global Operations and R&D | 5,000 0.0126% | $22.44 | $112,200 | -43.32% | |
| 2022-04-28 | Sale | Helsel Dave | SVP Global Operations and R&D | 3,513 0.009% | $22.44 | $78,832 | -37.25% | |
| 2022-04-12 | Sale | JOHNSON WESLEY | director | 1,299 0.0034% | $23.26 | $30,215 | -34.97% | |
| 2022-04-11 | Sale | JOHNSON WESLEY | 7,500 0.0197% | $23.05 | $172,838 | -31.92% | ||
| 2022-01-12 | Trowbridge Stephen A | EVP and CFO | 2,000 0.0052% | $22.64 | $45,280 | -6.16% | ||
| 2022-01-11 | Clemmer James C | President and CEO | 20,000 0.0498% | $22.84 | $456,800 | -11.60% | ||
| 2021-10-20 | Sale | Helsel Dave | SVP Global Operations and R&D | 6,988 0.0176% | $27.97 | $195,454 | -21.70% | |
| 2021-10-15 | Sale | Centea Scott | Sr. VP/GM, Global VIT | 24,000 0.0627% | $27.92 | $670,080 | -18.23% | |
| 2021-10-05 | Sale | Campbell Chad Thomas | SVP/GM, Vascular Access | 21,496 0.0543% | $27.15 | $583,616 | -17.96% | |
| 2021-04-14 | Sale | Helsel Dave | SVP Global Operations and R&D | 7,000 0.0182% | $23.93 | $167,510 | +6.62% | |
| 2021-01-20 | Sale | JOHNSON WESLEY | director | 13,000 0.0335% | $18.53 | $240,890 | +35.77% | |
| 2020-08-11 | Trowbridge Stephen A | EVP and CFO | 2,026 0.0055% | $9.38 | $19,004 | +123.55% | ||
| 2020-07-31 | Clemmer James C | President and CEO | 80,000 0.2097% | $8.26 | $660,800 | +131.23% | ||
| 2019-10-25 | Clemmer James C | President and CEO | 30,000 0.0787% | $14.19 | $425,700 | -24.88% | ||
| 2019-07-16 | Sale | Gould Kevin J | director | 27,300 0.0724% | $21.45 | $585,585 | -32.15% | |
| 2018-11-07 | Sale | Greiner Michael | EVP and CFO | 3,878 0.0103% | $21.53 | $83,493 | -6.26% |
Insider Historical Profitability
| Clemmer James C | President and CEO | 539066 1.1301% | $5.76 | 7 | 0 | +14.85% |
| STERN HOWARD S | director, 10 percent owner | 1647687 4.1342% | $5.76 | 0 | 35 | |
| Burgstahler David F | 381406 0.957% | $5.76 | 0 | 3 | ||
| Avista Capital Partners GP, LLC | 10 percent owner | 381406 0.957% | $5.76 | 0 | 3 | |
| MEYERS DAVID P | director | 336980 0.8455% | $5.76 | 0 | 33 | |
| HOBBS EAMONN P | President & CEO | 100401 0.2519% | $5.76 | 3 | 27 | +11.48% |
| Trowbridge Stephen A | EVP and CFO | 89581 0.2248% | $5.76 | 3 | 2 | +31.3% |
| BUCCI VINCENT | director | 86696 0.2175% | $5.76 | 9 | 0 | <0.0001% |
| JOHNSON WESLEY | director | 79704 0.2% | $5.76 | 2 | 3 | <0.0001% |
| Gould Kevin J | director | 55124 0.1383% | $5.76 | 3 | 1 | +8.54% |
| DONNELLY HOWARD W | director | 47600 0.1194% | $5.76 | 3 | 1 | +17.81% |
| Centea Scott | Sr. VP/GM, Global VIT | 46244 0.116% | $5.76 | 0 | 1 | |
| DEVIVO JOSEPH | President and CEO | 38000 0.0953% | $5.76 | 4 | 0 | <0.0001% |
| ECHENBERG PAUL S | Director Emeritus | 31976 0.0802% | $5.76 | 0 | 1 | |
| Campbell Chad Thomas | SVP/GM, Vascular Access | 31741 0.0796% | $5.76 | 0 | 1 | |
| Kapusta Matthew C | SVP, Business Development | 27005 0.0678% | $5.76 | 2 | 0 | +8.01% |
| GOLD JEFFREY | director | 25233 0.0633% | $5.76 | 1 | 1 | +6.67% |
| Meteny Dennis S | director | 21950 0.0551% | $5.76 | 2 | 0 | +16.07% |
| Greiner Charles R | VP - Global Franchise | 20910 0.0525% | $5.76 | 0 | 5 | |
| Richard Stark | SVP, GM - Oncology | 20754 0.0521% | $5.76 | 0 | 4 | |
| Greiner Michael | EVP and CFO | 20731 0.052% | $5.76 | 0 | 1 | |
| Helsel Dave | SVP Global Operations and R&D | 19189 0.0481% | $5.76 | 0 | 5 | |
| Keltjens Jan | President & CEO | 15000 0.0376% | $5.76 | 4 | 0 | +18.72% |
| LaPorte Steve | director | 8013 0.0201% | $5.76 | 8 | 0 | +1.5% |
| Shea Paul J | VP - Sales | 2562 0.0064% | $5.76 | 0 | 13 | |
| Orsatti Charles Thomas | director | 2000 0.005% | $5.76 | 1 | 0 | +20% |
| FLAHERTY ROBERT E | director | 1200 0.003% | $5.76 | 1 | 0 | +19.04% |
| ROSSELL ROBERT M | VP - Marketing | 1000 0.0025% | $5.76 | 1 | 7 | +116.9% |
| Stern Linda B | 10 percent owner | 891 0.0022% | $5.76 | 0 | 26 | |
| RECINELLA DANIEL | VP - Product Development | 892 0.0022% | $5.76 | 0 | 3 | |
| APPLING WILLIAM M | Vice-President - Research | 654 0.0016% | $5.76 | 0 | 17 | |
| Casciaro Gregory D | director | 500 0.0013% | $5.76 | 1 | 0 | +19.04% |
| REED JAN STERN | director | 316 0.0008% | $5.76 | 1 | 0 | +2.38% |
| GERARDI JOSEPH G | Vice President | 242 0.0006% | $5.76 | 0 | 25 | |
| KUNST BRIAN | VP - Regulatory Affairs | 0 0% | $5.76 | 0 | 6 | |
| MAPES HAROLD | VP - Operations | 0 0% | $5.76 | 0 | 12 |
Institutional Investor Ownership
| BlackRock | $27.49M | 11.69 | 4.68M | -7.17% | -$2.12M | <0.01 | |
| The Vanguard Group | $13.11M | 5.58 | 2.23M | -1.57% | -$209,007.24 | <0.0001 | |
| Systematic Financial Management LLC | $11.43M | 4.86 | 1.95M | +0.75% | +$84,733.46 | 0.32 | |
| Morgan Stanley | $11.02M | 4.68 | 1.88M | -0.51% | -$56,070.26 | <0.01 | |
| Dimensional Fund Advisors | $7.96M | 3.38 | 1.36M | -8.98% | -$784,936.44 | <0.01 | |
| Millennium Management LLC | $7.42M | 3.16 | 1.26M | -31.17% | -$3.36M | 0.01 | |
| Renaissance Technologies | $6.68M | 2.84 | 1.14M | +31.76% | +$1.61M | 0.01 | |
| Paradigm Capital Management Inc Ny | $6.33M | 2.69 | 1.08M | New | +$6.33M | 0.3 | |
| State Street | $5.98M | 2.54 | 1.02M | +0.85% | +$50,622.88 | <0.0001 | |
| Acadian Asset Management | $5.94M | 2.53 | 1.01M | +11.91% | +$632,411.59 | 0.02 | |
| Geode Capital Management | $5.34M | 2.27 | 909,076 | +1.37% | +$72,021.27 | <0.0001 | |
| Armistice Capital Llc | $5.12M | 2.18 | 872,000 | +9% | +$422,640.00 | 0.06 | |
| Citadel Advisors LLC | $5M | 2.13 | 851,503 | -16.01% | -$952,542.58 | <0.01 | |
| Assenagon Asset Management S.A. | $4.76M | 2.03 | 811,332 | -23.02% | -$1.42M | 0.01 | |
| Jacobs Levy Equity Management | $4.03M | 1.71 | 686,040 | -18.55% | -$917,252.11 | 0.02 | |
| Two Sigma Advisers LP | $3.98M | 1.69 | 678,000 | -1.75% | -$71,027.00 | 0.01 | |
| JPMorgan Chase | $3.9M | 1.66 | 663,903 | -5.9% | -$244,303.55 | <0.0001 | |
| Two Sigma | $3.45M | 1.47 | 587,098 | -10.41% | -$400,422.02 | 0.01 | |
| D. E. Shaw & Co. | $3.37M | 1.43 | 574,160 | -5.01% | -$177,808.16 | 0.01 | |
| Fund 1 Investments Llc | $3.12M | 1.33 | 531,891 | +7.04% | +$205,449.99 | 0.51 | |
| Western Standard Llc | $3.07M | 1.31 | 523,393 | +878.54% | +$2.76M | 4.15 | |
| ROYCE & ASSOCIATES INC | $3.02M | 1.29 | 514,935 | New | +$3.02M | 0.03 | |
| Segall Bryant & Hamill | $2.58M | 1.1 | 439,241 | +0.97% | +$24,871.19 | 0.05 | |
| AQR Capital | $2.38M | 1.01 | 406,295 | -41.48% | -$1.69M | <0.01 | |
| Acuitas Investments, LLC | $2.37M | 1.01 | 403,280 | 0% | +$0 | 1.24 | |
| Nuveen | $2.21M | 0.94 | 375,750 | -12.7% | -$320,965.80 | <0.01 | |
| Point72 Asset Management | $2.12M | 0.9 | 360,442 | +17,063.9% | +$2.1M | <0.01 | |
| Northern Trust | $2M | 0.85 | 340,273 | -2.18% | -$44,518.09 | <0.0001 | |
| Panagora | $1.96M | 0.83 | 333,888 | +52.6% | +$675,549.10 | 0.01 | |
| Rice Hall James & Associates, LLC | $1.94M | 0.82 | 329,896 | -0.3% | -$5,793.69 | 0.12 | |
| Charles Schwab | $1.87M | 0.8 | 318,378 | +4.68% | +$83,547.72 | <0.0001 | |
| Marshall Wace | $1.68M | 0.71 | 285,957 | +1,437.4% | +$1.57M | <0.01 | |
| Arrowstreet Capital, Limited Partnership | $1.43M | 0.61 | 243,217 | +6.1% | +$82,145.36 | <0.01 | |
| Royal Bank of Canada | $1.24M | 0.53 | 210,802 | +38.28% | +$342,442.71 | <0.0001 | |
| Ameriprise Financial | $1.21M | 0.51 | 205,831 | -7.86% | -$103,077.20 | <0.0001 | |
| Engineers Gate Manager Lp | $1.16M | 0.5 | 198,360 | +6.54% | +$71,514.20 | 0.03 | |
| Cubist Systematic Strategies | $1.16M | 0.49 | 196,834 | -26.57% | -$418,167.21 | 0.01 | |
| Kennedy Capital Management Inc | $1.12M | 0.48 | 190,236 | +425.02% | +$903,991.48 | 0.02 | |
| ExodusPoint Capital Management, LP | $1.11M | 0.47 | 189,660 | -69.88% | -$2.58M | 0.01 | |
| Mitsubishi UFJ Kokusai Asset Management | $1.1M | 0.47 | 187,622 | -7.05% | -$83,541.83 | <0.01 | |
| Connor Clark & Lunn Investment Management Ltd | $1.07M | 0.46 | 182,851 | +34.33% | +$274,281.53 | <0.01 | |
| Goldman Sachs | $981,593.00 | 0.42 | 167,222 | -14.03% | -$160,162.93 | <0.0001 | |
| State of Wisconsin Investment Board | $942,722.00 | 0.4 | 160,600 | -6.9% | -$69,853.00 | <0.01 | |
| BNY Mellon | $935,265.00 | 0.4 | 159,330 | -20.42% | -$239,953.32 | <0.0001 | |
| Envestnet Asset Management Inc | $931,681.00 | 0.4 | 158,719 | +27.52% | +$201,076.95 | <0.0001 | |
| Invesco | $893,966.00 | 0.38 | 152,294 | +138.4% | +$518,972.70 | <0.0001 | |
| Qube Research & Technologies | $845,274.00 | 0.36 | 143,999 | +80.18% | +$376,155.41 | <0.01 | |
| Shay Capital Llc | $733,750.00 | 0.31 | 125,000 | +66.67% | +$293,500.00 | 0.22 | |
| Bank of America | $720,513.00 | 0.31 | 122,745 | -14.65% | -$123,721.96 | <0.0001 | |
| Factorial Partners Llc | $683,855.00 | 0.29 | 116,500 | +31.64% | +$164,360.00 | 0.39 |